Back
Day Range
$12.50
$16.60
52-Week Range
$8.87
$16.61
Volume
2,000
50D / 200D Avg
$15.46
/
$13.20
Prev Close
$16.60
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 30.7 | 0.3 |
| P/B | 3.1 | 2.9 |
| ROE % | 10.7 | 3.7 |
| Net Margin % | 7.4 | 3.8 |
| Rev Growth 5Y % | 0.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.84
$0.83 – $0.85
|
670 M | 1 |
| FY2026 |
$0.77
$0.76 – $0.78
|
630 M | 1 |
Key Takeaways
Revenue grew 0.83% annually over 5 years — modest growth
Earnings declined -15.92% over the past year
ROE of 10.68% — decent returns on equity
Debt/Equity of 0.09 — conservative balance sheet
Generating 73.61M in free cash flow
P/E of 30.66 — premium valuation
Growth
Revenue Growth (5Y)
0.83%
Revenue (1Y)4.38%
Earnings (1Y)-15.92%
FCF Growth (3Y)N/A
Quality
Return on Equity
10.68%
ROIC12.53%
Net Margin7.35%
Op. Margin13.17%
Safety
Debt / Equity
0.09
Current Ratio3.10
Interest Coverage95.69
Valuation
P/E Ratio
30.66
P/B Ratio3.11
EV/EBITDA15.36
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.38% | Revenue Growth (3Y) | -7.63% |
| Earnings Growth (1Y) | -15.92% | Earnings Growth (3Y) | -5.15% |
| Revenue Growth (5Y) | 0.83% | Earnings Growth (5Y) | -1.14% |
| Profitability | |||
| Revenue (TTM) | 590.63M | Net Income (TTM) | 43.40M |
| ROE | 10.68% | ROA | 6.91% |
| Gross Margin | 22.28% | Operating Margin | 13.17% |
| Net Margin | 7.35% | Free Cash Flow (TTM) | 73.61M |
| ROIC | 12.53% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 3.10 |
| Interest Coverage | 95.69 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 30.66 | P/B Ratio | 3.11 |
| P/S Ratio | 2.25 | PEG Ratio | -1.26 |
| EV/EBITDA | 15.36 | Dividend Yield | 0.02% |
| Market Cap | 1.33B | Enterprise Value | 1.19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 590.63M | 565.85M | 692.29M | 673.58M | 571.40M |
| Net Income | 43.40M | 51.61M | 48.24M | 55.11M | 45.44M |
| EPS (Diluted) | 0.54 | 0.63 | 0.59 | 0.69 | 0.57 |
| Gross Profit | 131.57M | 238.80M | 252.08M | 243.47M | 206.09M |
| Operating Income | 77.77M | 78.31M | 72.74M | 81.00M | 64.86M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 627.65M | 740.72M | 719.21M | 735.89M | 650.69M |
| Total Liabilities | 200.33M | 329.92M | 343.75M | 379.25M | 362.99M |
| Shareholders' Equity | 427.31M | 385.02M | 375.46M | 313.19M | 269.37M |
| Total Debt | 38.06M | 46.72M | 73.63M | 82.92M | 60.50M |
| Cash & Equivalents | 174.29M | 147.47M | 131.04M | 162.81M | 181.36M |
| Current Assets | 508.93M | 637.48M | 553.01M | 570.10M | 514.05M |
| Current Liabilities | 164.33M | 170.69M | 285.61M | 316.43M | 301.75M |